BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

Seeking Alpha / 1 hour from now 1 Views

Presentation to Focus on Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO) 
Presentation to Focus on Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)
Read more

Comments